FLT1: a potential therapeutic target in sepsis-associated ARDS?
Lancet Respir Med
.
2020 Mar;8(3):219-220.
doi: 10.1016/S2213-2600(19)30404-7.
Epub 2020 Jan 23.
Author
Ian P Hall
1
Affiliation
1
Division of Respiratory Medicine and NIHR Nottingham Biomedical Research Centre, Queens Medical Centre, Nottingham NG7 2UH, UK. Electronic address: ian.hall@nottingham.ac.uk.
PMID:
31982042
DOI:
10.1016/S2213-2600(19)30404-7
No abstract available
Publication types
Comment
MeSH terms
Dyspnea
Genome-Wide Association Study
Humans
Respiratory Distress Syndrome*
Sepsis*
Vascular Endothelial Growth Factor Receptor-1
Substances
FLT1 protein, human
Vascular Endothelial Growth Factor Receptor-1
Grants and funding
G1000861/MRC_/Medical Research Council/United Kingdom
MC_PC_12010/MRC_/Medical Research Council/United Kingdom